دورية أكاديمية
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment
| العنوان: | Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment |
|---|---|
| المؤلفون: | Jo L. Dehoorne, Helena Groth, Emma Carlé, Ilse De Schrijver, Celine Sys, Patricia Delbeke, Elke O. Kreps, Thomas Renson, Carolien Bonroy |
| المصدر: | Pediatric Rheumatology Online Journal, Vol 21, Iss 1, Pp 1-11 (2023) |
| بيانات النشر: | BMC, 2023. |
| سنة النشر: | 2023 |
| المجموعة: | LCC:Pediatrics LCC:Diseases of the musculoskeletal system |
| مصطلحات موضوعية: | Pediatric noninfectious uveitis, Adalimumab, Therapeutic range, Trough levels, Therapeutic drug monitoring, Pediatrics, RJ1-570, Diseases of the musculoskeletal system, RC925-935 |
| الوصف: | Abstract Background Adalimumab is currently considered the most efficacious anti-TNFα agent for childhood noninfectious uveitis (NIU). The objective of this study was to define a therapeutic range for adalimumab trough levels in the treatment of childhood NIU. Methods A retrospective, observational, pilot study of 36 children with NIU aged |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1546-0096 |
| Relation: | https://doaj.org/toc/1546-0096 |
| DOI: | 10.1186/s12969-023-00928-2 |
| URL الوصول: | https://doaj.org/article/a36938333bc7459b99d2d5631678c5ed |
| رقم الأكسشن: | edsdoj.36938333bc7459b99d2d5631678c5ed |
| قاعدة البيانات: | Directory of Open Access Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 15460096 |
|---|---|
| DOI: | 10.1186/s12969-023-00928-2 |